Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-10-05 Sale | 2021-10-05 5:37 pm | XERIS PHARMACEUTICALS INC | XERS | Schmid John P. Director | 5,659 | $0 | $0 | 0 (Direct) | View |
| 2021-10-05 Sale | 2021-10-05 5:36 pm | XERIS PHARMACEUTICALS INC | XERS | Edick Paul R Chief Executive Officer | 621,494 | $0 | $0 | 0 (Indirect Direct) | View |
| 2021-10-05 Sale | 2021-10-05 5:36 pm | XERIS PHARMACEUTICALS INC | XERS | Pieper Steven Chief Financial Officer | 158,108 | $0 | $0 | 0 (Direct) | View |
| 2021-10-05 Sale | 2021-10-05 5:34 pm | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 494,780 | $0 | $0 | 0 (Direct) | View |
| 2021-10-05 Sale | 2021-10-05 5:34 pm | XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks | 206,366 | $0 | $0 | 0 (Direct) | View |
| 2021-10-05 Sale | 2021-10-05 5:33 pm | XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks | 89,583 | $0 | $0 | 0 (Direct) | View |
| 2021-10-05 Sale | 2021-10-05 5:32 pm | XERIS PHARMACEUTICALS INC | XERS | Shannon John Patrick Jr See Remarks | 263,829 | $0 | $0 | 0 (Direct) | View |
| 2021-04-12 Sale | 2021-04-13 5:06 pm | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 10,000 | $4.0725 | $40,725 | 496,824 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-07-28 Option Award | 2021-07-29 6:06 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | Pieper Steven See Remarks | 100,000 | $0 | 158,858 (Direct) | View |
Ownership | 2021-07-29 6:04 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | Pieper Steven See Remarks | 0 | $0 | 132,768 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-08 7:11 pm | N/A 2031-06-08 | XERIS PHARMACEUTICALS INC | XERS | PERSKY MARLA Director | 11,228 | $0 | 11,228 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-08 7:10 pm | N/A 2031-06-08 | XERIS PHARMACEUTICALS INC | XERS | SHERMAN JEFFREY W Director | 11,228 | $0 | 11,228 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-08 7:09 pm | N/A 2031-06-08 | XERIS PHARMACEUTICALS INC | XERS | HALKUFF DAWN Director | 11,228 | $0 | 11,228 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-08 7:08 pm | N/A 2031-06-08 | XERIS PHARMACEUTICALS INC | XERS | Schmid John P. Director | 11,228 | $0 | 11,228 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-08 7:08 pm | N/A 2031-06-08 | XERIS PHARMACEUTICALS INC | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | 11,228 | $0 | 11,228 (Direct) | View |